The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II randomized trial of GM.CD40L vaccine plus/minus CCL21 in advanced lung adenocarcinoma: Final results.
 
Jhanelle Elaine Gray
Honoraria - Genentech
Consulting or Advisory Role - Celgene; Lilly
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Alberto Chiappori
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Novartis; Pfizer
Speakers' Bureau - Boehringer Ingelheim; Celgene; Genentech; Merck; Novartis; Pfizer
 
Charles C. Williams
Speakers' Bureau - Genentech
 
Tawee Tanvetyanon
No Relationships to Disclose
 
Eric B. Haura
Research Funding - Lilly; Novartis
Patents, Royalties, Other Intellectual Property - Patent pending on PLA technology related to kinase inhibitor sensitivity biomarkers
 
Ben C. Creelan
Honoraria - Boehringer Ingelheim
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb
Research Funding - Boehringer Ingelheim (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Rebecca D. Devane
No Relationships to Disclose
 
Renee Smilee
No Relationships to Disclose
 
David Noyes
No Relationships to Disclose
 
Jongphil Kim
No Relationships to Disclose
 
Scott Joseph Antonia
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck